Moleculin Biotech
MBRX
MBRX
26 hedge funds and large institutions have $5.61M invested in Moleculin Biotech in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
35% less capital invested
Capital invested by funds: $8.57M → $5.61M (-$2.96M)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$87K | |
| 2 | +$80K | |
| 3 | +$64.5K | |
| 4 |
Renaissance Technologies
New York
|
+$62K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$41K |
Top Sellers
| 1 | -$88K | |
| 2 | -$43K | |
| 3 | -$14K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| 5 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$2.74K |